ProMIS Neurosciences (PMN) Exchange Rate Effect (2021 - 2023)
ProMIS Neurosciences' (PMN) quarterly Exchange Rate Effect came in at -$237265.0 in Q3 2023, up 31.69% YoY from -$180162.8 in Q3 2022, and down 721.42% on a QoQ basis from $38181.0 in Q2 2023.
ProMIS Neurosciences (PMN) Exchange Rate Effect (2021 - 2023) Analysis & Trends
ProMIS Neurosciences (PMN) has 3 years of Exchange Rate Effect data on file, last reported at -$237265.0 in Q3 2023.
- Quarterly Exchange Rate Effect rose 31.69% year-over-year to -$237265.0 in Q3 2023, while the trailing twelve-month figure through Dec 2023 was -$181425.0 (up 65.57% YoY) and the FY2023 annual result came in at -$181425.0, up 65.57% from the prior year.
- Exchange Rate Effect retreated to -$237265.0 in Q3 2023, from $38181.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $179131.0 in Q1 2022 to a low of -$372655.0 in Q2 2022.
- A 3-year average of -$110455.6 and a median of -$790.0 in 2021 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect jumped 1870.25% — and 2023, when it sank 90.14%.
- Tracing PMN's Exchange Rate Effect over 3 years: stood at -$790.0 in 2021, then jumped by 1870.25% to $13985.0 in 2022, then sank by 1796.57% to -$237265.0 in 2023.
- The last three Exchange Rate Effect figures came in at -$237265.0 (Q3 2023), $38181.0 (Q2 2023), and $17659.0 (Q1 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - | - |
| 10 | ProMIS Neurosciences | 135.44 Mn | 81.98 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -237,265.00 |
| Sep 30, 2023 | -237,265.00 |
| Jun 30, 2023 | 38,181.00 |
| Jun 30, 2023 | 38,181.00 |
| Mar 31, 2023 | 17,659.00 |
| Mar 31, 2023 | 17,659.00 |
| Dec 31, 2022 | 13,985.00 |
| Dec 31, 2022 | 13,985.00 |
| Sep 30, 2022 | -347,360.00 |
| Sep 30, 2022 | -347,360.00 |
| Jun 30, 2022 | -372,655.00 |
| Jun 30, 2022 | -372,655.00 |
| Mar 31, 2022 | 179,131.00 |
| Mar 31, 2022 | 179,131.00 |
| Dec 31, 2021 | -790.00 |
| Dec 31, 2021 | -790.00 |
| Sep 30, 2021 | -284,986.00 |
| Sep 30, 2021 | -284,986.00 |